DA-9601 inhibits activation of the human mast cell line HMC-1 through inhibition of NF-κB
- First Online:
- Cite this article as:
- Lee, S., Park, HH., Son, HY. et al. Cell Biol Toxicol (2007) 23: 105. doi:10.1007/s10565-006-0103-3
Mast cell-mediated allergic inflammation is involved in many diseases such as asthma, sinusitis, and rheumatoid arthritis. Mast cells induce synthesis and production of pro-inflammatory cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 with immune regulatory properties. The formulated ethanol extract of Artemisia asiatica Nakai (DA-9601) has been reported to have antioxidative and anti-inflammatory activities. In this report, we investigated the effect of DA-9601 on the expression of pro-inflammatory cytokines by the activated human mast cell line HMC-1 and studied its possible mechanisms of action. DA-9601 dose-dependently decreased the gene expression and production of TNF-α, IL-1β, and IL-6 on phorbol 12-myristate 13-acetate (PMA)- and calcium ionophore A23187-stimulated HMC-1 cells. In addition, DA-9601 attenuated PMA- and A23187-induced activation of NF-κB as indicated by inhibition of degradation of IκBα, nuclear translocation of NF-κB, NF-κB/DNA binding, and NF-κB-dependent gene reporter assay. Our in vitro studies provide evidence that DA-9601 might contribute to the treatment of mast cell-derived allergic inflammatory diseases.
Keywordsallergic inflammation DA-9601 mast cell NF-κB pro-inflammatory cytokine
enzyme-linked immunosorbent assay
electrophoretic mobility shift assays
human mast cell line
phorbol 12-myristate 13-acetate
reverse-transcriptase polymerase chain reaction
tumor necrosis factor
Unable to display preview. Download preview PDF.